CSTE Overdose Anomaly Toolkit: Laboratory Data

Laboratory Data

Last Updated: March 2022

Laboratory data includes test orders and results and can be a source of information about overdoses, including new and emerging drug threats. Hospital, commercial, forensic, public health, or criminal justice laboratories testing human specimens and drug samples can provide reliable laboratory evidence that can inform overdose response efforts. Testing, particularly for non-fatal overdoses may not be routinely done since laboratory confirmation isn’t always necessary to treat a person who overdosed. Hospitals performing presumptive drug screens (e.g., immunoassays) may require additional definitive confirmation to confirm the presence of specific drug compounds, due to the lack of sensitivity among these screening tests. Forensic, state, or public health laboratories may be equipped to conduct definitive laboratory-based drug tests which may provide additional context for surveillance by identifying the concentrations of drugs present in patients at hospital presentation1. 

Reference

1APHL Opioids Biosurveillance Task Force Model Opioids Biosurveillance Strategy for Public Health Practice. Available at: https://www.aphl.org/aboutAPHL/publications/Documents/EH-2020-Opioid-Biosurveillance-Strategy.pdf 

Toolkit Resources

Get more insights by using our toolkit resources.
Go to Resources

Glossary

Learn the definition of the key words being used.
Go to Glossary

Thanks

Thank you, to all of our contributors.
View our contributors

CSTE white logo
Using the power of epidemiology to improve
the public’s health.

Contact Us

Have any questions or recommendations, you can contact us at overdose@cste.org